MedTrace Logo

Fecal Microbiota Transplantation for Irritable Bowel Syndrome Associated Food Intolerance

NCT05361785 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2022-05-13

No results posted yet for this study

Summary

Previous studies have shown that stool transplantation (FMT) have positive effect in symptoms for some patients with irritable bowel syndrome (IBS). Studies have shown that it is possible by FMT to reverse the microbiome of the recipient's intestine in the direction of the microbiome of the donor. The effect on eating habits for engraftment of microbiome by FMT is unknown.

The purpose of this study is to investigate whether FMT relieves FODMAP diet extension without worsening intestinal symptoms in IBS patients.

Conditions

  • Irritable Bowel Syndrome
  • Fecal Microbiota Transplantation

Interventions

BIOLOGICAL

FMT

FMT from healthy donor or placebo

Sponsors & Collaborators

  • Turku University Hospital

    collaborator OTHER_GOV

  • University of Helsinki

    collaborator OTHER

  • Paijat-Hame Hospital District

    collaborator OTHER

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Perttu Arkkila, Professor · Head physician

  • Perttu Lahtinen, Md. · Head physician

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-30
Primary Completion
2024-07-31
Completion
2026-07-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05361785 on ClinicalTrials.gov